This Aardvark Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday – Foghorn Therapeutics (NASDAQ:FHTX), Aardvark Therapeutics (NASDAQ:AARD)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• BTIG analyst Jeet Mukherjee initiated coverage on Aardvark Therapeutics, Inc. (NASDAQ:AARD) with a Buy rating and announced a price target of $26. Aardvark Therapeutics shares closed at $9.87 on Thursday. See how other analysts view this stock.
• UBS analyst Timothy Arcuri initiated coverage on Impinj, Inc. (NASDAQ:PI) with a Neutral rating and announced a price target of $200. Impinj shares closed at $169.06 on Thursday. See how other analysts view this stock.
• Guggenheim analyst Michael Schmidt initiated coverage on Foghorn Therapeutics Inc. (NASDAQ:FHTX) with a Buy rating and announced a price target of $12. Foghorn Therapeutics shares closed at $4.00 on Thursday. See how other analysts view this stock.

Considering buying AARD stock? Here’s what analysts think:

Read This Next:

• Top 2 Real Estate Stocks That May Fall Off A Cliff This Month

Photo via Shutterstock